Neomacrolides in cystic fibrosis

A. Bush (London, United Kingdom)

Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease

Session: Non-antibiotic effects of macrolides in lung disease
Session type: Symposium
Number: 3066

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Bush (London, United Kingdom). Neomacrolides in cystic fibrosis. Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Cystic fibrosis fibrosis bronchiectasis Source: Virtual Congress 2020 – Paediatric year in review Year: 2020
Transition in cystic fibrosis Source: International Congress 2017 – PG16 Transition of children and adolescents into adult care Year: 2017
Diagnosing bronchiectasis and cystic fibrosis Source: International Congress 2018 – ME8 Diagnosing bronchiectasis and cystic fibrosis Year: 2018
CFTR: cystic fibrosis and beyond Source: Eur Respir J 2014; 44: 1042-1054 Year: 2014
Cystic fibrosis Source: Eur Respir Mon; 2009: 45: 32–45 Year: 2009
Cystic fibrosis Source: Annual Congress 2013 –Paediatric Year in Review Year: 2013
Cystic fibrosis Source: Eur Respir Monogr 2013; 62: 54-69 Year: 2013
Cystic fibrosis Source: Eur Respir Mon; 2010: 47: 225–239 Year: 2010
Cystic fibrosis Source: Annual Congress 2012 - Maurizio Vignola Award for Innovation in Pneumology Ceremony (supported by Chiesi Foundation) followed by Clinical Year in Review I Year: 2012
Cystic fibrosis Source: Annual Congress 2004 - Paediatric year in review Year: 2004
Cystic fibrosis Source: School Course 2014 - Pulmonary Rehabilitation Year: 2014
Cystic fibrosis Source: Eur Respir Monogr 2017; 77: 167-180 Year: 2017
Cystic fibrosis Source: International Congress 2014 – Paediatric Year in Review Year: 2014
Cystic fibrosis Source: ERS Course 2015 Year: 2015
Cystic fibrosis Source: Eur Respir Monogr 2017; 77: 25-37 Year: 2017
Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases Year: 2018
Immuno-allertypes in non-cystic fibrosis bronchiectasis Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018
Non-cystic fibrosis bronchiectasis Source: Virtual Congress 2020 – Paediatric year in review Year: 2020